Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492

By sjmartinez • February 21, 2025

Girard N, Besada M, Rogula B, Lucherini S, Vo L, Chaudhary MA, Goring S, Lozano-Ortega G, Tran M, Varol N, Waser N, Yu WW, Lee JM, Spicer J. Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492. Cancers (Basel). 2025 Feb 17;17(4):674. doi: 10.3390/cancers17040674. Erratum for: Cancers (Basel). 2024 Jul 08;16(13):2492. doi: 10.3390/cancers16132492. PMID: 39976394.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Keykhaei M, Sandhu AT, Hsue PY, Greene SJ, Ziaeian B, Kittleson M, Villarreal-Gonzalez M, Hallaj S, Ramsis M, Agarwal MA, Fonarow GC. National Impact of[...]

Feasibility, acceptability, and usability of a novel self-monitoring program utilizing a consumer-grade wearable device paired with sleep-related patient-reported outcomes for veterans with obstructive sleep apnea

Mak S, Ghadimi S, Der-McLeod E, Naeem S, Moore V, Gil L, Chohan M, Zeidler M, Ash G, Fung C. Feasibility, acceptability, and usability of[...]

Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic diseases: real-world data from the ILD-PRO Registry

Bracken SJ, Weber JM, Neely ML, Swaminathan AC, Palmer SM, Wilfong EM, Chauffe AD, Volkmann ER. Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic[...]